Inventor · disambiguated record
Joseph L. Evans
Also filed as: EVANS JOSEPH · EVANS JOSEPH L
7 granted patents·3 pending applications·51 citations·filing 1995–2025
81Inventor score
Files withNANJING NUTRABUILDING BIO TECH CO LTD5PLEIOGENIX INC2SHAMAN PHARMACEUTICALS INC2PIONEER HI BRED INT1
Top patents by PatentIndex Score
10 records- 0190US12485106B2Methods of treating fibrotic liver diseases or conditions with indeglitazarPLEIOGENIX INC·Filed 2025·Granted Dec 2, 2025·1 cites·20 claims
- 0290US11534426B1Use of ergothioneine for extending lifespan or improving healthspanNANJING NUTRABUILDING BIO TECH CO LTD·Filed 2022·Granted Dec 27, 2022·4 cites·9 claims
- 0385US11491141B1Methods of treating glutathione deficiencies and deficiencies in glutathione synthetase activityNANJING NUTRABUILDING BIO TECH CO LTD·Filed 2022·Granted Nov 8, 2022·1 cites·18 claims
- 0483US5674900ATerpenoid-type quinones for treatment of diabetesSHAMAN PHARMACEUTICALS INC·Filed 1995·Granted Oct 7, 1997·38 cites·25 claims
- 0580US12257234B2Methods of treating fibrotic liver diseases or conditions with indeglitazarPLEIOGENIX INC·Filed 2024·Granted Mar 25, 2025·0 cites·22 claims
- 0676US12485110B2Use of ergothioneine for extending lifespan or improving healthspanNANJING NUTRABUILDING BIO TECH CO LTD·Filed 2022·Granted Dec 2, 2025·0 cites·18 claims
- 0764US2025073211A1Use of ergothioneine to suppress deleterious effects of senescenceNANJING NUTRABUILDING BIO TECH CO LTD·Filed 2024·Application pending·0 cites
- 0856US5747527AFuranoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetesSHAMAN PHARMACEUTICALS INC·Filed 1995·Granted May 5, 1998·7 cites·13 claims
- 0956US2025073210A1Use of Ergothioneine for Enhancing Glutathione LevelNANJING NUTRABUILDING BIO TECH CO LTD·Filed 2022·Application pending·0 cites
- 1050US2023183724A1Methods and compositions for multiplexed editing of plant cell genomesPIONEER HI BRED INT·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph L. Evans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →